Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Publications indexed to the term Histocompatibility Antigens Class II

FacultyTitle
1Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68. (Lee J, Cullum E, Stoltz K, Bachmann N, Strong Z, Millick DD, Denzin LK, Chang A, Tarakanova V, Chervonsky AV, Golovkina T) J Immunol 2021 Dec 15;207(12):2944-2951    
1MHC Class II Presentation Is Affected by Polymorphism in the H2-Ob Gene and Additional Loci. (Cullum E, Graves AM, Tarakanova VL, Denzin LK, Golovkina T) J Immunol 2021 Jul 01;207(1):5-14       1 Citation
1Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance. (Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ) Proc Natl Acad Sci U S A 2017 Jan 31;114(5):1099-1104       54 Citations
1Krüppel-like factor KLF10 deficiency predisposes to colitis through colonic macrophage dysregulation. (Papadakis KA, Krempski J, Svingen P, Xiong Y, Sarmento OF, Lomberk GA, Urrutia RA, Faubion WA) Am J Physiol Gastrointest Liver Physiol 2015 Dec 01;309(11):G900-9       19 Citations
1T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function. (Fu J, Wang D, Yu Y, Heinrichs J, Wu Y, Schutt S, Kaosaard K, Liu C, Haarberg K, Bastian D, McDonald DG, Anasetti C, Yu XZ) J Immunol 2015 Jan 01;194(1):388-97       33 Citations
1Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. (Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL) Transplantation 2013 Jan 27;95(2):389-96       67 Citations
1Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. (Curtis BR, McFarland JG) Crit Care Med 2006 May;34(5 Suppl):S118-23       87 Citations
1A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. (Zavala-Ruiz Z, Strug I, Anderson MW, Gorski J, Stern LJ) Chem Biol 2004 Oct;11(10):1395-402       45 Citations
1Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. (Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M, Hurley C, Kollman C, Anasetti C, Noreen H, Begovich A, Hildebrand W, Petersdorf E, Schmeckpeper B, Setterholm M, Trachtenberg E, Williams T, Yunis E, Weisdorf D) Blood 2004 Oct 01;104(7):1923-30       599 Citations
1Primitive endothelial cell lines from the porcine embryonic yolk sac. (Plendl J, Gilligan BJ, Wang SJ, Lewis R, Shinners B, Vandenbroeck K, Auerbach R) In Vitro Cell Dev Biol Anim 2002 Jun;38(6):334-42       16 Citations
1Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. (Girvin AM, Gordon KB, Welsh CJ, Clipstone NA, Miller SD) Blood 2002 May 15;99(10):3692-701       48 Citations
1Improving the outcome of unrelated donor stem cell transplantation by molecular matching. (Shaw BE, Madrigal JA, Potter M) Blood Rev 2001 Dec;15(4):167-74       20 Citations
1Electrofusion of a weakly immunogenic neuroblastoma with dendritic cells produces a tumor vaccine. (Orentas RJ, Schauer D, Bin Q, Johnson BD) Cell Immunol 2001 Oct 10;213(1):4-13       56 Citations
1The cell biology of antigen presentation. (Hudson AW, Ploegh HL) Exp Cell Res 2002 Jan 01;272(1):1-7       31 Citations
2Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation. (Carstens C, Newman DK, Bohlen H, König A, Koch N) Int Immunol 2000 Nov;12(11):1561-8       9 Citations
1Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture. (Kersh GJ, Engle DL, Williams CB, Allen PM) J Immunol 2000 Jun 01;164(11):5675-82       10 Citations
1A kinetic threshold between negative and positive selection based on the longevity of the T cell receptor-ligand complex. (Williams CB, Engle DL, Kersh GJ, Michael White J, Allen PM) J Exp Med 1999 May 17;189(10):1531-44       98 Citations
1Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler's virus. (Njenga MK, Murray PD, McGavern D, Lin X, Drescher KM, Rodriguez M) J Neuropathol Exp Neurol 1999 Jan;58(1):78-91       31 Citations
1In vivo antagonism of a T cell response by an endogenously expressed ligand. (Basu D, Williams CB, Allen PM) Proc Natl Acad Sci U S A 1998 Nov 24;95(24):14332-6       36 Citations
1In vivo expression of a TCR antagonist: T cells escape central tolerance but are antagonized in the periphery. (Williams CB, Vidal K, Donermeyer D, Peterson DA, White JM, Allen PM) J Immunol 1998 Jul 01;161(1):128-37       30 Citations
1IFN-gamma-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. (Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD) J Immunol 1997 Jan 15;158(2):614-21       140 Citations
1Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. (Hoffmann ML, Jablonski LM, Crum KK, Hackett SP, Chi YI, Stauffacher CV, Stevens DL, Bohach GA) Infect Immun 1994 Aug;62(8):3396-407       65 Citations
1What determines who develops graft-versus-host disease: the graft or the host (or both)? (Gale RP, Horowitz MM, Butturini A, Barrett AJ, Kolb HJ) Bone Marrow Transplant 1992 Aug;10(2):99-102       7 Citations
1Heated lymphocytes express HLA-DR antigens despite their inability to stimulate in MLC. (Brewer JA, Hank JA, Wendel T, Schmeling GJ, Blank JL, Morrissey LW, Robins HI, Sondel PM) Tissue Antigens 1983 Oct;22(4):246-56       26 Citations
1Pharmacological modification of immunoregulatory T lymphocytes . II. Modulation of T lymphocyte cell surface characteristics. (Birch RE, Rosenthal AK, Polmar SH) Clin Exp Immunol 1982 Apr;48(1):231-8       41 Citations